Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if DANAHER CORP (NYSE:DHR) is suited for quality investing. Investors should of couse do their own research, but we spotted DANAHER CORP showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.
Some of the quality metrics of NYSE:DHR highlighted
DANAHER CORP has demonstrated significant revenue growth over the past 5 years, with a 15.19% increase. This underscores the company's ability to adapt to market dynamics and capitalize on growth opportunities.
DANAHER CORP demonstrates impressive performance in terms of ROIC excluding cash and goodwill, with a 71.12% ratio. This highlights the company's efficient utilization of capital and its focus on maximizing returns for investors.
With a Debt/Free Cash Flow Ratio of 2.76, DANAHER CORP exhibits solid financial health and responsible debt management practices. This ratio indicates the company's ability to generate ample free cash flow to meet its debt obligations and pursue growth opportunities.
DANAHER CORP demonstrates consistent Profit Quality over the past 5 years, with a strong 122.0%. This indicates the company's ability to generate sustainable and reliable profits, showcasing its long-term profitability and financial stability.
DANAHER CORP has consistently achieved strong EBIT growth over the past 5 years, with a 27.56% increase. This underscores the company's effective management of its operating income and suggests a positive outlook for future profitability.
DANAHER CORP demonstrates a remarkable trend where its EBIT 5-year growth exceeds its Revenue 5-year growth. This indicates the company's ability to enhance its profitability through improved cost control and operational efficiency.
What is the full fundamental picture of NYSE:DHR telling us.
Every day ChartMill assigns a Fundamental Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple fundamental indicators and properties.
DHR gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Life Sciences Tools & Services industry. DHR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DHR has a decent growth rate and is not valued too expensively.
More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.
Disclaimer
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.